for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. appeals court upholds ruling that canceled Teva Copaxone patents

(Reuters) - A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone.

The ruling was a victory for a group of generic drug companies, including Mylan NV, that challenged the validity of Teva’s patents in order to sell generic versions.

Reporting by Jan Wolfe; Editing by Bernadette Baum

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up